Aoxing Pharmaceutical Company, Inc.

AOXG

US03740A1060

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:04:37 2024-04-26 am EDT			5-day change	1st Jan Change
0.0051 ^USD	-.--%		-.--%	+64.52%

2017	Aoxing Pharmaceutical Company, Inc. Executive Changes	CI
2017	Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	CI

Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt

October 12, 2015

Aoxing Pharmaceutical Company, Inc. filed its 10-K on Oct 13, 2015 for the period ending Jun 30, 2015. In this report its auditor, BDO China Shu Lun Pan, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc. Executive Changes	17-08-04	CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	17-05-15	CI
Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016	17-02-13	CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016	16-11-13	CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016	16-10-04	CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016	16-05-16	CI
Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016	16-02-08	CI
Aoxing Pharmaceutical Company, Inc. Announces Executive Changes	16-02-01	CI
Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai	15-12-10	CI
Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center	15-12-04	CI
Aoxing Pharmaceutical Company, Inc. Announces Management Changes	15-12-01	CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015	15-11-13	CI
Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt	15-10-12	CI
Aoxing Pharmaceutical Company, Inc. Announces Consolidated Earnings Results for the Year Ended June 30, 2015; Provides Earnings Guidance for the Fiscal Year 2016	15-10-12	CI
Aoxing Pharmaceutical Company, Inc. Announces Management Changes	14-12-29	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Year Ended June 30, 2014	14-09-29	CI
Aoxing Pharmaceutical Company, Inc. Appoints Zhimin Li to its Board	14-08-06	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	14-05-14	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Second Quarter and Six Month Periods Ended December 31, 2013	14-02-19	CI
Aoxing Pharmaceutical Company, Inc. Announces Financial Results for the First Quarter Ended September 30, 2013	13-11-14	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Year Ended June 30, 2013	13-10-15	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Third Quarter and Nine Month Periods Ended March 31, 2013	13-05-15	CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Second Quarter and Six Months Ended December 31, 2012	13-02-15	CI
Aoxing Pharmaceutical Company, Inc. Announces Receipt of Production License for Pholcodine	13-01-28	CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2012	12-11-14	CI

Chart Aoxing Pharmaceutical Company, Inc.

Duration

Period

Chart Aoxing Pharmaceutical Company, Inc.

More charts

Company Profile

Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The Company holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AOXING PHARMACEUTICAL COMPANY, INC.	+64.52%	389K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
CIPLA LIMITED	+12.33%	13.54B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B

Generic Pharmaceuticals